Nortem BioGroup Logo

Nortem BioGroup

MLBIO | PA

Overview

Corporate Details

ISIN(s):
ES0105719001
LEI:
959800CHLXTS5M688863
Country:
Spain
Address:
Alexander Humboldt 12, 11500 Puerto de Santa María, El
Sector:
Health Care
Industry:
Biotechnology

Description

At Nortem BioGroup we work every day to improve the lives of our consumers through natural, innovative and healthy products. Our main objective is to understand and satisfy the needs of our customers, from the conception of the product to its final sale. That is why we are committed to developing exceptional products made with the highest quality ingredients, stringent control measures and continuous improvement through research and innovation. Through innovative development processes, we provide our consumers with clinically effective products, using natural ingredients in their production, thus improving the health and well-being of our customers.

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Herantis Pharma Oyj Logo Herantis Pharma Oyj Finland HRTIS
Hiron-Trade Investments & Industrial Buildings Ltd. Israel HRON
Human Stem Cells Institute PJSC Logo Human Stem Cells Institute PJSC Russian Federation ISKJ
Human Xtensions Ltd. Logo Human Xtensions Ltd. Israel HUMX
Hybrigenics SA Logo Hybrigenics SA France ALHYG
Hyloris Pharmaceuticals SA Logo Hyloris Pharmaceuticals SA Belgium HYL
Ikonisys S.A. Logo Ikonisys S.A. France ALIKO
IMCB PJSC Logo IMCB PJSC Russian Federation GEMA
Inify Laboratories AB Logo Inify Laboratories AB Sweden INIFY
Innate Pharma Logo Innate Pharma France IPH